share_log

復星醫藥:更改香港主要營業地點的地址

FOSUN PHARMA: CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG

HKEX ·  Dec 19 17:00

Summary by Futu AI

復星醫藥於2024年12月19日宣佈,自2025年1月10日起,公司香港主要營業地點的地址將發生變更。新地址為香港銅鑼灣希慎道33號利園一期19樓1917室,原地址為香港九龍觀塘道348號宏利廣場5樓。此次地址變更反映了公司在香港業務發展的新階段。新地址位於香港核心商業區,可能有助於提升公司在香港的業務效率和形象。公司董事會主席吳以芳先生已對此變更作出正式公告。
復星醫藥於2024年12月19日宣佈,自2025年1月10日起,公司香港主要營業地點的地址將發生變更。新地址為香港銅鑼灣希慎道33號利園一期19樓1917室,原地址為香港九龍觀塘道348號宏利廣場5樓。此次地址變更反映了公司在香港業務發展的新階段。新地址位於香港核心商業區,可能有助於提升公司在香港的業務效率和形象。公司董事會主席吳以芳先生已對此變更作出正式公告。
FOSUN PHARMA announced on December 19, 2024, that starting January 10, 2025, the address of the company's main business location in Hong Kong will change. The new address is Room 1917, 19th Floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong, while the original address was 5th Floor, Manulife Financial Centre, 348 Kwun Tong Road, Kowloon, Hong Kong.This change of address reflects a new phase in the company's business development in Hong Kong. The new address is located in the core business district of Hong Kong, which may help enhance the company's business efficiency and image in Hong Kong. The chairman of the Board of Directors, Mr. Wu Yifang, has made a formal announcement regarding this change.
FOSUN PHARMA announced on December 19, 2024, that starting January 10, 2025, the address of the company's main business location in Hong Kong will change. The new address is Room 1917, 19th Floor, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong, while the original address was 5th Floor, Manulife Financial Centre, 348 Kwun Tong Road, Kowloon, Hong Kong.This change of address reflects a new phase in the company's business development in Hong Kong. The new address is located in the core business district of Hong Kong, which may help enhance the company's business efficiency and image in Hong Kong. The chairman of the Board of Directors, Mr. Wu Yifang, has made a formal announcement regarding this change.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.